Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Phase 1

Completed

Conditions: Castration Resistant Prostate Cancer
Prostate Cancer

Interventions: Drug: Enzalutamide
Drug: CC-115

First Posted Date: 2016-07-14

Last Posted Date: 2023-01-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT02833883

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

and more 2 locations

A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma

Interventions: Drug: Selinexor
Drug: Ixazomib
Drug: Dexamethasone

First Posted Date: 2016-07-13

Last Posted Date: 2020-11-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT02831686

Locations: 🇺🇸
Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 4 locations

A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors

Phase 2

Completed

Conditions: Merkel Cell Carcinoma
Melanoma
Other Solid Tumors

Interventions: Drug: TALIMOGENE LAHERPAREPVEC (TVEC)
Radiation: Hypofractionated Radiotherapy

First Posted Date: 2016-06-30

Last Posted Date: 2024-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT02819843

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

Not Applicable

Withdrawn

Conditions: Allo-SCT Patients
Adult Allo-SCT Survivor

Interventions: Other: web-based patient education
Behavioral: questionnaire

First Posted Date: 2016-06-23

Last Posted Date: 2016-09-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT02812082

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Utility of Intra-operative Image Guidance System for Missing Metastases

Completed

Conditions: Colorectal Cancer
Metastatic to the Liver

First Posted Date: 2016-06-20

Last Posted Date: 2023-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT02806037

Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers

Phase 1

Completed

Conditions: EGFR-mutant Lung Cancers
Non-small Cell Lung Cancer

Interventions: Drug: osimertinib
Drug: Bevacizumab

First Posted Date: 2016-06-16

Last Posted Date: 2023-09-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 49

Registration Number: NCT02803203

Locations: 🇺🇸
Memorial Sloan Kettering commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 4 locations

T-Cell Therapy for Advanced Breast Cancer

Phase 1

Active, not recruiting

Conditions: Breast Cancer
Metastatic HER2-negative Breast

Interventions: Drug: Cyclophosphamide
Biological: Mesothelin-targeted T cells
Drug: AP1903

First Posted Date: 2016-06-07

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 186

Registration Number: NCT02792114

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Consent and follow-up only), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (Consent and follow-up only), Basking Ridge, New Jersey, United States

and more 4 locations

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Phase 1

Active, not recruiting

Conditions: Lymphoma
Relapsed/Refractory T-cell Lymphomas

Interventions: Drug: Romidepsin
Drug: Bortezomib
Drug: duvelisib

First Posted Date: 2016-05-26

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 114

Registration Number: NCT02783625

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
University of Washington School of Medicine in St. Louis, Saint Louis, Missouri, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

and more 8 locations

Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma

Phase 2

Active, not recruiting

Conditions: Adenoid Cystic Carcinoma

Interventions: Drug: Lenvatinib

First Posted Date: 2016-05-23

Last Posted Date: 2024-06-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 33

Registration Number: NCT02780310

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States

and more 2 locations

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: skin punch biopsy

First Posted Date: 2016-05-13

Last Posted Date: 2024-07-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 120

Registration Number: NCT02772367

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy